Pharma Pulse 12/9/24: Embracing AI in Pharma, Millions Could Benefit from Magic Mushrooms & more
The latest news for pharma industry insiders.
Pharmaceutical Executive recently brought together a group of experts to discuss the current state of AI within the pharmaceutical industry. The technology has become a major talking point across all industries over the past year-and-a-half, but it has been around for much longer than that. The technology’s ability to collect, sort, analyze, and generate results from large data sets makes it especially interesting for the pharma industry, where experts often find themselves limited by the massive amounts of data they must work with.
In the first part of our discussion, we covered the overall perception of AI and how this is impacting adoption. The technology can be used in any area of pharma, including drug development all the way up to marketing. Like any new technology, however, there is confusion surrounding what exactly it can do. There is also hesitation about how it should be used and where it makes sense to implement.
Study Estimates 5 Million People Could Benefit from Magic Mushrooms for Depression Treatment
Psilocybin-assisted therapy, which involves using the active ingredient from "magic mushrooms," could benefit roughly 5 million people currently receiving treatment for major depressive disorder and treatment-resistant depression if the FDA approves it.
OpenAI Adds $200 Monthly ChatGPT Pro Subscription With New Model
OpenAI is introducing a higher-priced paid tier for its chatbot ChatGPT that includes unlimited access to its most powerful artificial intelligence models, including an improved version of its software that can perform human-like reasoning tasks.
The new ChatGPT Pro option, announced in a livestreamed event on Thursday, will cost $200 a month and offer access to an expanded version of o1, its reasoning model. OpenAI previously introduced a preview of the model in September, but the company said the new version is faster and better at solving competitive math and code problems.
Cencora announced the launch of Accelerate Pharmacy Solutions, a unified portfolio of solutions designed to help hospital and health systems customers optimize operations and improve financial performance.
Accelerate Pharmacy Solutions brings together Cencora’s suite of pharmacy and supply chain solutions, enabling Cencora to deliver an enhanced customer experience and integrated support to address customers’ evolving needs. The solutions range from specialty drug purchasing and cost management strategies to logistics, transport, supply chain and inventory management solutions.
Want to understand the Gross-to-Net bubble? Check out William Roth's feature column in Pharmaceutical Commerce Magazine. The first part is out now: https://lnkd.in/erZGJkPn
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs
